Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92256779 | 9225677 | 9 | F | 201505 | 20160713 | 20130411 | 20160719 | EXP | US-GLAXOSMITHKLINE-A1019646A | GLAXOSMITHKLINE | 55.50 | YR | F | Y | 77.30000 | KG | 20160719 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92256779 | 9225677 | 1 | PS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 37 NG/KG/MIN, CONC: 45,000 NG/ML, PUMP RATE 82 ML/DAY, VIAL STRENGTH 1.5 MG | N513 | 20444 | 37 | DF | POWDER FOR INFUSION | ||||||
| 92256779 | 9225677 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | UNK | S506 | 20444 | POWDER FOR INFUSION | |||||||||
| 92256779 | 9225677 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 38 NG/KG/MIN CONTINUOUSLY | T856 | 20444 | POWDER FOR INFUSION | ||||||||
| 92256779 | 9225677 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 38 NG/KG/MIN CONTINUOUSLY | T794 | 20444 | POWDER FOR INFUSION | ||||||||
| 92256779 | 9225677 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 38 NG/KG/MIN CONTINUOUS | U383 | 20444 | 38 | DF | POWDER FOR INFUSION | ||||||
| 92256779 | 9225677 | 6 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 37 NG/KG/MIN | U383 | 20444 | POWDER FOR INFUSION | |||||||||
| 92256779 | 9225677 | 7 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 37 NG/KG/MIN CONTINUOUSLY | T366 | 20444 | 37 | DF | POWDER FOR INFUSION | |||||||
| 92256779 | 9225677 | 8 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | 38 DF, UNK | Z111 | 20444 | 38 | DF | POWDER FOR INFUSION | |||||||
| 92256779 | 9225677 | 9 | SS | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
| 92256779 | 9225677 | 10 | C | REVATIO | SILDENAFIL CITRATE | 1 | U | 0 | |||||||||||
| 92256779 | 9225677 | 11 | C | WARFARIN | WARFARIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92256779 | 9225677 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92256779 | 9225677 | OT |
| 92256779 | 9225677 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92256779 | 9225677 | Back injury | |
| 92256779 | 9225677 | Back pain | |
| 92256779 | 9225677 | Dental operation | |
| 92256779 | 9225677 | Device leakage | |
| 92256779 | 9225677 | Diarrhoea | |
| 92256779 | 9225677 | Epistaxis | |
| 92256779 | 9225677 | Headache | |
| 92256779 | 9225677 | Open fracture | |
| 92256779 | 9225677 | Oral surgery | |
| 92256779 | 9225677 | Pain in extremity | |
| 92256779 | 9225677 | Pain in jaw | |
| 92256779 | 9225677 | Pneumonia | |
| 92256779 | 9225677 | Rash | |
| 92256779 | 9225677 | Spinal fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92256779 | 9225677 | 1 | 20090409 | 0 | ||
| 92256779 | 9225677 | 2 | 20090410 | 0 | ||
| 92256779 | 9225677 | 6 | 20090409 | 0 |